c-FLIP is involved in erythropoietin-mediated protection of erythroid-differentiated cells from TNF-α-induced apoptosis

Cell Biology International

Volumn 34, Issue 6, 2010, Pages 621-630

  Vittori, Daniela ^a   Vota, Daiana ^a   Callero, Mariana ^a   Chamorro, María E ^a   Nesse, Alcira ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Cellular FLICE inhibitory protein (c FLIP); Erythroid differentiation; Erythropoietin; K562 cells; Tumour necrosis factor (TNF ); UT 7 cell

Indexed keywords

ERYTHROPOIETIN; FLICE INHIBITORY PROTEIN; HEMIN; PHOSPHATIDYLINOSITOL 3 KINASE; TUMOR NECROSIS FACTOR ALPHA; CFLAR PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN K 562; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; ERYTHROID CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOWN-REGULATION; ERYTHROID CELLS; ERYTHROPOIETIN; HEMIN; HUMANS; K562 CELLS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955076287     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090085     Document Type: Article

References (30)

1. Benito A, Silva M, Grillot D, Nuñez G, Fernández-Luna JL. Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-xL. Blood 1996;87:3837-43.
2. Bittorf T, Büchse T, Sasse T, Jaster R, Brock J. Activation of the transcription factor NF-kB by the erythropoietin receptor. Structural requirements and biological significance. Cell Signal 2001;13:673-81.
3. Chung I-J, Dai Ch, Krantz SB. Stem cell factor increases the expression of FLIP that inhibits IFNc-induced apoptosis in human erythroid progenitor cells. Blood 2003;101:1324-8.
4. Feng Q. Beyond erythropoiesis: the anti-inflammatory effects of erythropoietin. Cardiovasc Res 2006;71:615-7.
5. Haseyama Y, Sawada K, Oda A, Koizumi K, Takano H, Tarumi T et al. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood 1999;94:1568-77.
6. Hietakangas V, Poukkula M, Heiskanen K, Karvinen J, Sistonen L, Eriksson J. Erythroid differentiation sensitises K562 Leukemia cells to TRAIL-induced apoptosis by downregulation of c-FLIP. Mol Cell Biol 2003;23:1278-91.
7. Jacobs-Helber SM, Roh K, Bailey D, Dessypris EN, Ryan JJ, Chen J et al. Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia. Blood 2003;101:524-31.
8. Khosravi-Far R, Esposti MD. Death receptor signals to mitochondria. Cancer Biol Ther 2004;3:1051-7.
9. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M et al. Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte- macrophage colony-stimulating factor, interleukin-3, or erythropoietin for growth and survival. Cancer Res 1991; 51:341-8.
10. Lewis JL, Marley SB, Ojo M, Gordon MY. Opposing effects of PI3 kinase pathway activation on human myeloid and erythroid progenitor cell proliferation and differentiation in vitro. Exp Hematol 2004;32: 36-44.
11. Li X-F, Anderson J, Hutzler D, Roodman D. Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-α. Exp Hematol 1989;17:1059-62.
12. Liu R, Fan C, Liu G, Olashaw NE, Zuckerman KS. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-alpha supported proliferation of leukaemia and lymphoma cell lines. J Biol Chem 2000;275:21086-93.
13. Lowry OH. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
14. McKinney M, Robbins M. Chronic atropine administration up-regulates rat cortical muscarinic m1 receptor mRNA molecules: assessment with the RT/PCR. Brain Res Mol Brain Res 1992;12:39-45.
15. Means RT. Recent developments of anaemia of chronic disease. Curr Hematol Rep 2003;2:116-21.
16. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kB signals induce the expression of c-FLIP. Mol Cel Biol 2001;21: 5299-305.
17. Panka DJ, Mano T, Suhara T, Walsh K, Mier J. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem 2001;276:6893-6.
18. Perez D, White E. E1A sensitises cells to tumor necrosis factor alpha by downregulating c-FLIP. J Virol 2003;77:2651-62.
19. Pérez G, Garbossa G, Sassetti B, Di Risio C, Nesse A. Interference of aluminium on iron metabolism in erythroleukaemia K562 cells. J Inorg Biochem 1999;76:105-12.
20. Peter M. The flip side of FLIP. Biochem J 2004;382:e1-e3.
21. Rae C, MacEwan DJ. Granulocyte macrophage-colony stimulating factor and interleukin-3 increase expression of type II tumor necrosis factor receptor, increasing susceptibility to tumor necrosis factorinduced apoptosis. Control of leukaemia cell life/death switching. Cell Death Differ 2004;11:S162-71
22. Ratajczak J, Kucia M, Reca R, Zhang J, Machalinski B, Ratajczak M. Quiescent CD34+ early erythroid progenitors are resistant to several erythropoietic "inhibitory" cytokines: role of FLIP. Br J Haematol 2003;123:160-9.
23. Rippo MR, Moretti S, Vescovi S, Tomasetti M, Orecchia S, Amici G et al. FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells. Oncogene 2004; 23:7753-60.
24. Roodman GD, Bird A, Hutzler D, Montgomery W. Tumor necrosis factoralpha and hematopoietic progenitors: effects of Tumor Necrosis Factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp Hematol 1987;15:928-35.
25. Rusten LS, Jacobsen SE. Tumor necrosis factor (TNF)-a inhibits human erythropoiesis in vitro: role of p55 and p75 TNF receptors. Blood 1995;85:989-96.
26. Sambrook J, Russell D. Molecular cloning. A laboratory manual. New York: Cold Spring Harbor Laboratory Press; 2001. pp. 7.1-7.88.
27. Testa U. Apoptotic mechanisms in the control of erythropoiesis. Leukemia 2004;18:1176-99.
28. Tucker SJ, Rae C, Littlejohn AF, Paul A, MacEwan DJ. Switching leukemia cell phenotype between life and death. Proc Natl Acad Sci USA 2004;101:12940-5.
29. Vittori D, Pregi N, Pérez G, Garbossa G, Nesse A. The distinct erythropoietin functions that promote cell survival and proliferation are affected by aluminum exposure through mechanisms involving erythropoietin receptor. Biochim Biophys Acta 2005;1743:29-36.
30. + cells. Exp Hematol 2002;30:1238-47.